Medicine guide

AIMOVIG

As listed in the register: AIMOVIG

140 mg · solution

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Erenumab
Made by
Novartis Pharmaceuticals Canada Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupPain, sleep, mood, epilepsy and the brainN02CD01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byNovartis Pharmaceuticals Canada Inc
Active substanceErenumab
Used inPain, sleep, mood, epilepsy and the brain
Strength140 mg
Formsolution
ClassificationN02CD01 · Pain, sleep, mood, epilepsy and the brain
Routesubcutaneous
Dispensing (as stated by the register)PRESCRIPTION · SCHEDULE D
StatusApproved
MarketedNo — authorised but not currently marketed, according to the register
DIN02487292
DPD drug code97745

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.